Stay updated on IBI310 Combo vs Sorafenib in HCC Clinical Trial
Sign up to get notified when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.

Latest updates to the IBI310 Combo vs Sorafenib in HCC Clinical Trial page
- Check6 days agoChange DetectedThe record history now includes revision v3.4.3 and removes v3.4.2 from the history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe history page adds Revision: v3.4.2 and removes the government funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check41 days agoChange DetectedAdded a site-wide funding-status banner noting potential delays and that the NIH Clinical Center is open, and updated the page revision to v3.4.1 from v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check48 days agoChange DetectedMinor UI updates on the history page introduce a glossary display, color-coded change explanations, and updated revision notes (v3.4.0 replacing v3.3.4) with a capitalization change for 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check84 days agoChange DetectedA new Revision: v3.3.3 entry was added to the Record History, and the HHS Vulnerability Disclosure link along with the Revision: v3.3.2 entry were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check106 days agoChange DetectedThe Record History now includes a new revision entry (v3.3.2) with the prior revision (v3.3.1) in the version list; this is a maintenance update and does not affect study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IBI310 Combo vs Sorafenib in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.